No takes yet. Share an insight, caveat, or question.
Review uncovers multifaceted molecular and cellular drivers of pituitary neuroendocrine tumours, highlighting the need for multi-omic classification schemes to improve prognosis.
Sabatino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: